Average Co-Inventor Count = 3.41
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (26 from 3,684 patents)
2. Bristol-myers Squibb (4 from 36 patents)
3. Bristol Meyers Squibb Company (2 from 41 patents)
4. Brilstol-myers Squibb (1 from 1 patent)
33 patents:
1. 8124730 - Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v
2. 8124729 - Splice variants of human G-protein coupled receptor HGPRBMY29 (HGPRMBY29SV2)
3. 7846671 - Methods of screening for agents that modulate the interaction of RGS and Gαq and urinary incontinence
4. 7713699 - Methods of diagnosing colon adenocarcinoma using mRNA encoding the human g-protein coupled receptor, HGPRBMY23
5. 7635758 - Antibodies directed to G-protein coupled receptor HGPRBMY29sv1
6. 7531310 - Methods of diagnosing Crohn's disease by measuring expression level of RNA encoding human G-protein coupled receptor, HGPRBMY11
7. 7517652 - Methods of diagnosing tumors using the G-protein coupled receptor (GPCR), RAI-3
8. 7417121 - Human G-protein coupled receptor, HGPRBMY39
9. 7371822 - Human G-protein coupled receptor variant of HM74, HGPRBMY74
10. 7358074 - Human phosphatase RET31, and variants thereof
11. 7348149 - Methods of diagnosing Parkinson's disease by measuring expression level of RNA encoding human protein HLLRCR-1
12. 7345148 - Human G-protein coupled receptor, HGPRBMY29sv1 polypeptides
13. 7344860 - Polynucleotide encoding a novel human P2X7 splice variant, HBMYP2X7v
14. 7339032 - Human relaxin receptor HGPRBMY5v1
15. 7312086 - Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23